Virotherapy Research in Germany: From Engineering to Translation-Reference-Cited by-同舟云学术

Virotherapy Research in Germany: From Engineering to Translation

Published:2017-10 Issue:10 Volume:28 Page:800-819
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Ungerechts Guy¹²³,Engeland Christine E.¹²,Buchholz Christian J.⁴⁵,Eberle Jürgen⁶,Fechner Henry⁷,Geletneky Karsten⁸,Holm Per Sonne⁹,Kreppel Florian¹⁰,Kühnel Florian¹¹,Lang Karl Sebastian¹²,Leber Mathias F.¹²,Marchini Antonio¹³¹⁴,Moehler Markus¹⁵,Mühlebach Michael D.¹⁶,Rommelaere Jean¹³,Springfeld Christoph¹,Lauer Ulrich M.¹⁷¹⁸,Nettelbeck Dirk M.¹⁹

Affiliation:

1. Department of Medical Oncology, National Center for Tumor Diseases and Heidelberg University Hospital, Heidelberg, Germany.

2. Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany.

3. Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

4. Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.

5. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), partner site Heidelberg, Germany.

6. Charité –Universitätsmedizin Berlin, Department of Dermatology, Skin Cancer Centre Charité, Berlin, Germany.

7. Technische Universität Berlin, Institute of Biotechnology, Department of Applied Biochemistry, Berlin, Germany.

8. Department of Neurosurgery, Klinikum Darmstadt, Darmstadt, Germany.

9. Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

10. Chair of Biochemistry and Molecular Medicine, Center for Biomedical Research and Education (ZBAF), Faculty of Health, University Witten/Herdecke (UW/H), Witten, Germany.

11. Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.

12. Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

13. Department of Tumor Virology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.

14. Laboratory of Oncolytic Virus Immuno-Therapeutics (LOVIT), Luxembourg Institute of Health (LIH), Strassen, Luxembourg.

15. University Medical Center Mainz, I. Dept. of Internal Medicine, Mainz, Germany.

16. Product Testing of Immunological Veterinary Medicinal Products, Paul-Ehrlich-Institut, Langen, Germany.

17. Department of Clinical Tumor Biology, Medical University Hospital, Tübingen, Germany.

18. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), partner site Tübingen, Germany.

19. German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.138

Reference114 articles.

1. Oncolytic Viruses: Exploiting Cancer's Deal with the Devil

2. Oncolytic virotherapy

3. Oncolytic viruses: a new class of immunotherapy drugs

4. Oncolytic viruses: finally delivering

5. Trial Watch—Oncolytic viruses and cancer therapy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors;Viruses;2024-05-14

2. The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy;Cureus;2023-06-21

3. Performance of a linear controller on nonlinear model of drug and virus delivery in cancer chemovirotherapy: A comparison between continuous and discrete approaches;Scientia Iranica;2022-10-31

4. Efficient recovery of attenuated canine distemper virus from cDNA;Virus Research;2022-07

5. Gene Therapy “Made in Germany”: A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy;Human Gene Therapy;2021-10-01